MSD's Zoe Armstrong on the opportunity for 'permanent positive change'

BioPharmaDispatch spoke with MSD's head of clinical research about the company's response to the COVID-19 pandemic, changes as a result of the loss of face-to-face interactions with stakeholders and preparations for trials in the post-pandemic world. …